+7 495 640-17-71
info@dna-technology.com
ENG
RUS
This is perhaps one of the most widely discussed and debated questions in reproductive medicine. Seeking to move closer to an answer based on the results of their own research, physicians from leading Austrian clinics specializing in assisted reproductive technologies (ART), together with specialists from DNA-Technology, undertook a dedicated study. Follicular fluid samples from 24 women undergoing IVF/ICSI procedures were selected for analysis, and the microbial spectrum was assessed using the FEMOFLOR®16 and ANDROFLOR®. It was found that the absence of bacterial DNA correlates with a high probability of successful fertilization. The key role in predicting ART outcomes appears to belong to the overall microbial impact leading to disruption of the dynamic balance of the microbiota.
From March 19 to 21, 2026, the international conference Microbiome Throughout Life – Translating New Science into Clinical Practice was held in Belgrade, Serbia, bringing together over 200 participants and 55 international speakers from the fields of gastroenterology, obstetrics and gynecology, microbiology, immunology, neonatology, endocrinology, and biotechnology. DNA-Technology participated as a Platinum Sponsor and showcased its molecular diagnostic solutions for microbiome analysis.
Dear, wonderful colleagues of ours!
On this beautiful, sunny day, we want to give you more than just words—we want to offer you a sincere promise of reliable support.
We wish that every day brings you what every woman deserves: Trust, Reliability, and Quality in all things.
May your lives be filled with harmony and peace, and may all difficulties pass you by.
We are always here for you, ready to offer you the care and support that every woman needs.
Генетика